These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32755599)

  • 21. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
    Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.
    Shields RL; Namenuk AK; Hong K; Meng YG; Rae J; Briggs J; Xie D; Lai J; Stadlen A; Li B; Fox JA; Presta LG
    J Biol Chem; 2001 Mar; 276(9):6591-604. PubMed ID: 11096108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.
    Pace D; Lewis N; Wu T; Gillespie R; Leiske D; Velayudhan J; Rohrbach A; Connell-Crowley L
    Biotechnol Prog; 2016 Sep; 32(5):1181-1192. PubMed ID: 27160519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.
    Radaev S; Sun PD
    J Biol Chem; 2001 May; 276(19):16478-83. PubMed ID: 11297533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
    Wada R; Matsui M; Kawasaki N
    MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
    Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
    Cendron AC; Wines BD; Brownlee RT; Ramsland PA; Pietersz GA; Hogarth PM
    Mol Immunol; 2008 Jan; 45(2):307-19. PubMed ID: 17673295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.
    Berntzen G; Andersen JT; Ustgård K; Michaelsen TE; Mousavi SA; Qian JD; Kristiansen PE; Lauvrak V; Sandlie I
    J Biol Chem; 2009 Jan; 284(2):1126-35. PubMed ID: 18957413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies.
    Thomann M; Reckermann K; Reusch D; Prasser J; Tejada ML
    Mol Immunol; 2016 May; 73():69-75. PubMed ID: 27058641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation.
    Chen J; Dong JF; Sun C; Bergeron A; McBride L; Pillai M; Barnard MR; Salmon J; Michelson AD; Bray PF
    J Thromb Haemost; 2003 Feb; 1(2):355-62. PubMed ID: 12871511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the interaction between the neonatal Fc receptor and monoclonal antibody variants by hydrogen/deuterium exchange mass spectrometry.
    Jensen PF; Larraillet V; Schlothauer T; Kettenberger H; Hilger M; Rand KD
    Mol Cell Proteomics; 2015 Jan; 14(1):148-61. PubMed ID: 25378534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131).
    Cymer F; Thomann M; Wegele H; Avenal C; Schlothauer T; Gygax D; Beck H
    Biologicals; 2017 Nov; 50():125-128. PubMed ID: 28988621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
    Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending human IgG half-life using structure-guided design.
    Booth BJ; Ramakrishnan B; Narayan K; Wollacott AM; Babcock GJ; Shriver Z; Viswanathan K
    MAbs; 2018 Oct; 10(7):1098-1110. PubMed ID: 29947573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.
    Chen B; Vousden KA; Naiman B; Turman S; Sun H; Wang S; Vinall LMK; Kemp BP; Kasturiangan S; Rees DG; Grant E; Hinrichs MJ; Eck S; DiGiandomenico A; Jack Borrok M; Ly N; Xiong X; Gonzalez C; Morehouse C; Wang Y; Zhou Y; Cann J; Zhao W; Koelkebeck H; Okubo K; Mayadas TN; Howe D; Griffiths J; Kolbeck R; Herbst R; Sims GP
    Ann Rheum Dis; 2019 Feb; 78(2):228-237. PubMed ID: 30459279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life.
    Jensen PF; Schoch A; Larraillet V; Hilger M; Schlothauer T; Emrich T; Rand KD
    Mol Cell Proteomics; 2017 Mar; 16(3):451-456. PubMed ID: 28062799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
    Pollastrini J; Dillon TM; Bondarenko P; Chou RY
    Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antibody-C1q interactions by Biolayer Interferometry.
    Zhou W; Lin S; Chen R; Liu J; Li Y
    Anal Biochem; 2018 May; 549():143-148. PubMed ID: 29577875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry.
    Dzimianski JV; Lorig-Roach N; O'Rourke SM; Alexander DL; Kimmey JM; DuBois RM
    Sci Rep; 2020 Dec; 10(1):21738. PubMed ID: 33303951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.